Case report: Ensitrelvir for treatment of persistent COVID-19 in lymphoma patients: a report of two cases.

Front Immunol · 2024 · PMC10850233 · PMID 38333218

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Ensitrelvir (375mg on day 60, 125mg on days 61-64) was administered, and day 66 RT-qPCR testing showed a trend of improvement with a Ct value of 34.5 (E), and day 73 RT-qPCR testing became negative for the first time ( Figure 1A ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.